- Drug Pipelines
- February 2024
- 80 Pages
Global
From €1934EUR$2,000USD£1,638GBP
- Report
- July 2023
- 50 Pages
China
From €1741EUR$1,800USD£1,474GBP
- Report
- July 2023
- 104 Pages
China
From €1741EUR$1,800USD£1,474GBP
- Report
- July 2023
- 204 Pages
China
From €3868EUR$4,000USD£3,276GBP
- Report
- March 2020
- 194 Pages
Global
From €5193EUR$5,370USD£4,398GBP
The Flu Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat influenza. Flu drugs are typically antiviral medications that work to reduce the severity and duration of the flu virus. These drugs are typically taken orally or through an injection, and are used to treat both seasonal and pandemic flu. Commonly prescribed flu drugs include oseltamivir, zanamivir, and peramivir.
In addition to antiviral medications, the Flu Drug market also includes vaccines, which are used to prevent the flu virus from taking hold in the body. Vaccines are typically administered through an injection, and are recommended for people of all ages.
The Flu Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the companies in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Show Less Read more